People · Operator
Named in public records as an officer, director or promoter · active 2011–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Silvergate Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $30.8M | $156.4M | 2011 |
Mark Parrish at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Parrish on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Heron | 1 | 11 |
| Nathan Every | 1 | 5 |
| Bhaskar Chaudhuri | 1 | 3 |
| LAURA MEDINA | 1 | 2 |
| Frank Segrave | 1 | 1 |
| Michael Beckloff | 1 | 1 |
| Robert Mauro | 1 | 1 |
| Bhaskar Chauduri | 1 | 1 |
| Bhaskar Chaundhuri | 1 | 1 |
| Barry Barnard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.